BeiGene to Participate in 25th Annual Credit Suisse Healthcare Conference
read more...
Oct 07, 2016
BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenstrom’s Macroglobulinemia at 9th International Workshop on Waldenstrom’s Macroglobulinemia
read more...
Oct 04, 2016
BeiGene to Host Conference Call on BGB-3111 Data Presentation at IWWM-9
read more...
Oct 03, 2016
BeiGene Appoints Ross Pettit as Senior Vice President, Global Development Operations
read more...
Sep 11, 2016
BeiGene Receives Approval to Initiate Clinical Trials in China with PD-1 Antibody BGB-A317
read more...
Sep 06, 2016
BeiGene Appoints Jane Huang, M.D. as Chief Medical Officer, Hematology
read more...
Aug 31, 2016
BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences
read more...
Aug 24, 2016
BeiGene Appoints Amy Peterson, M.D. as Chief Medical Officer, Immuno-oncology
read more...
Aug 18, 2016
BeiGene Receives Approval to Initiate Clinical Trials in China with PARP Inhibitor BGB-290
read more...
Aug 10, 2016
BeiGene Reports Second Quarter 2016 Financial Results
read more...
Jul 05, 2016
BeiGene Announces First Patient Dosing for Investigational BTK Inhibitor BGB-3111 in China
read more...
Jun 29, 2016
BeiGene Announces Initiation of a Combination Trial of the BTK Inhibitor BGB-3111 with the PD-1 Antibody BGB-A317
read more...
Jun 06, 2016
BeiGene to Participate in Goldman Sachs 37th Annual Global Healthcare Conference
read more...
Jun 05, 2016
BeiGene Presents Initial Clinical Data on PD-1 Antibody BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting
read more...
May 19, 2016
BeiGene Announces Presentation on BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting
read more...
May 11, 2016
BeiGene Reports First Quarter 2016 Financial Results
read more...
May 04, 2016
BeiGene Appoints Dr. Ji Li as Executive Vice President, Global Head of Business Development
read more...
Apr 17, 2016
BeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting
read more...
Apr 11, 2016
BeiGene Appoints Eric Hedrick, M.D. as Interim Chief Medical Officer
read more...
Feb 08, 2016
BeiGene Announces Closing of Its Initial Public Offering
read more...
